AbCellera Biologics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $2.7M | $-1.3M | $4.0M | $890.0K |
| FY2020 | $22.7M | $13.0M | $9.7M | $8.4M |
| FY2021 | $244.6M | $186.1M | $58.5M | $30.6M |
| FY2022 | $277.4M | $206.7M | $70.7M | $49.5M |
| FY2023 | $-43.9M | $-120.8M | $76.9M | $64.2M |
| FY2024 | $-108.6M | $-187.0M | $78.4M | $67.6M |
| FY2025 | $-131.3M | $-174.1M | $42.8M | $55.8M |